NGS Group (NGS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Feb, 2026Executive summary
EBITA improved to 1.1 MSEK in Q4 2025 from 0.5 MSEK year-over-year, despite a 23% revenue decline to 67 MSEK due to a weaker healthcare staffing market.
Full-year EBITA reached 2.1 MSEK, a significant turnaround from -22.6 MSEK in 2024, with revenue down 19% to 283 MSEK.
Goodwill impairment of 30 MSEK in Q4 led to a reported EBIT of -28.9 MSEK for the quarter and -27.9 MSEK for the year.
The new Human Capital brand was positively received, and the group won new clients in both private and public sectors.
Financial highlights
Q4 net income was -29.8 MSEK (vs. -0.3 MSEK), EPS -1.20 SEK (vs. -0.01 SEK).
Full-year net income was -30.8 MSEK (vs. -71.9 MSEK), EPS -1.24 SEK (vs. -3.61 SEK).
Q4 operating cash flow was 1.8 MSEK (vs. 5.0 MSEK); full-year operating cash flow was -9.3 MSEK (vs. -19.5 MSEK).
No dividend proposed for the year.
Outlook and guidance
Management expects the Human Capital segment to benefit from an anticipated economic upturn in Sweden in 2026.
Strategic focus on digitalization, offering development, and cost savings, including office relocations for lower rent.
Latest events from NGS Group
- Q3 sales dropped 18% but EBITA improved; new CEO and Human Capital brand launched.NGS
Q3 20256 Nov 2025 - EBITA returned to positive in Q2 2025 amid revenue decline and challenging market conditions.NGS
Q2 20257 Aug 2025 - Q3 sales dropped 27% but profitability and equity ratio improved amid market challenges.NGS
Q3 202413 Jun 2025 - Sharp revenue decline and heavy losses in H1 2024; cost cuts and new deals target recovery.NGS
Q2 202413 Jun 2025 - EBITA improved despite a 20% sales drop, driven by cost control and business divestment.NGS
Q1 20256 Jun 2025 - Q4 EBITA returned to profit despite lower sales, driven by cost control and segment focus.NGS
Q4 20245 Jun 2025